Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $15.4 million.

  • Sotera Health's Gains from Investment Securities rose 452.73% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.0 million, marking a year-over-year increase of 4177.95%. This contributed to the annual value of $65.8 million for FY2024, which is 3110.73% up from last year.
  • Sotera Health's Gains from Investment Securities amounted to $15.4 million in Q3 2025, which was up 452.73% from $20.0 million recorded in Q2 2025.
  • Sotera Health's 5-year Gains from Investment Securities high stood at $23.4 million for Q4 2024, and its period low was $7.6 million during Q4 2023.
  • For the 5-year period, Sotera Health's Gains from Investment Securities averaged around $14.9 million, with its median value being $14.4 million (2023).
  • In the last 5 years, Sotera Health's Gains from Investment Securities skyrocketed by 40134.43% in 2021 and then crashed by 5992.53% in 2023.
  • Sotera Health's Gains from Investment Securities (Quarter) stood at $20.1 million in 2021, then decreased by 5.29% to $19.0 million in 2022, then tumbled by 59.93% to $7.6 million in 2023, then skyrocketed by 206.73% to $23.4 million in 2024, then crashed by 34.14% to $15.4 million in 2025.
  • Its last three reported values are $15.4 million in Q3 2025, $20.0 million for Q2 2025, and $12.2 million during Q1 2025.